RecruitingNCT05147519

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

Multinational Observational Cohort of HIV and Other Infections (MOCHI)


Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Enrollment

2,500 participants

Start Date

Nov 5, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Multinational Observational Cohort of HIV and other Infections (MOCHI). This observational study is to gain information regarding the number of new HIV infections among people who engage in behaviors that make them vulnerable to acquiring HIV across multiple international sites.


Eligibility

Min Age: 14 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This multinational observational study is following people who are at high risk for HIV and other sexually transmitted infections (STIs) over time. The study has multiple steps: Step 1 follows HIV-negative participants, Step 2 follows those who test positive for HIV during the study, and Step 3 tracks those who achieve viral suppression with treatment. **You may be eligible if...** - You are between 14 and 55 years old - You have a documented negative HIV test - You are considered at increased risk for HIV based on recent STIs, certain sexual behaviors, or injection drug use - You are willing to provide contact information and attend follow-up visits **You may NOT be eligible if...** - You have a significant medical, psychological, or social condition that would interfere with participation - You have active drug or alcohol dependence that would affect your ability to follow study requirements - You have previously participated in an HIV vaccine study (unless you received a placebo) - You are pregnant at the time of screening Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALNovel interventions to achieve HIV remission

To establish a group of well-characterized people living with HIV who initiated ART during acute or early HIV transmission that can serve as a source population for future studies, including those designed to test novel interventions to achieve HIV remission.


Locations(3)

Kenya Medical Research Institute/ USAMRD-A/Kenya (Kericho)

Kericho, Kenya

Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila

Manila, Philippines

Makerere University Walter Reed Program

Makerere, Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05147519


Related Trials